Guiu S - Search Results

1

Decision of Adjuvant Systemic Treatment in HR+ HER2- Early Invasive Breast Cancer: Which Biomarkers Could Help?

Alexandre M, Maran-Gonzalez A, Viala M, Firmin N, D'Hondt V, Gutowski M, Bourgier C, Jacot W, Guiu S. Alexandre M, et al. Among authors: guiu s. Cancer Manag Res. 2019 Dec 11;11:10353-10373. doi: 10.2147/CMAR.S221676. eCollection 2019. Cancer Manag Res. 2019. PMID: 31849525 Free PMC article. Review.

2

Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?

Guiu S, Wolfer A, Jacot W, Fumoleau P, Romieu G, Bonnetain F, Fiche M. Guiu S, et al. Crit Rev Oncol Hematol. 2014 Dec;92(3):235-57. doi: 10.1016/j.critrevonc.2014.07.003. Epub 2014 Jul 30. Crit Rev Oncol Hematol. 2014. PMID: 25129506 Review.

3

Targeting triple-negative breast cancer and high-grade ovarian carcinoma: refining BRCAness beyond BRCA1/2 mutations?

Jacot W, Theillet C, Guiu S, Lamy PJ. Jacot W, et al. Among authors: guiu s. Future Oncol. 2015;11(4):557-9. doi: 10.2217/fon.14.268. Future Oncol. 2015. PMID: 25686112 No abstract available.

4

Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study.

Dell'Ova M, De Maio E, Guiu S, Roca L, Dalenc F, Durigova A, Pinguet F, Bekhtari K, Jacot W, Pouderoux S. Dell'Ova M, et al. Among authors: guiu s. BMC Cancer. 2015 Oct 8;15:659. doi: 10.1186/s12885-015-1673-3. BMC Cancer. 2015. PMID: 26449988 Free PMC article.

5

Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases.

Jacot W, Pons E, Frenel JS, Guiu S, Levy C, Heudel PE, Bachelot T, D'Hondt V, Darlix A, Firmin N, Romieu G, Thezenas S, Dalenc F. Jacot W, et al. Among authors: guiu s. Breast Cancer Res Treat. 2016 Jun;157(2):307-318. doi: 10.1007/s10549-016-3828-6. Epub 2016 May 11. Breast Cancer Res Treat. 2016. PMID: 27167986

6

Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysis.

Jankowski C, Guiu S, Cortet M, Charon-Barra C, Desmoulins I, Lorgis V, Arnould L, Fumoleau P, Coudert B, Rouzier R, Coutant C, Reyal F. Jankowski C, et al. Among authors: guiu s. Breast Cancer Res Treat. 2017 Jan;161(1):73-81. doi: 10.1007/s10549-016-4040-4. Epub 2016 Nov 2. Breast Cancer Res Treat. 2017. PMID: 27807808

7

Prognostic impact of the inclusion of uPA/PAI-1 for adjuvant treatment decision-making in ER+/Her2- pN0 early breast cancers.

Viala M, Alexandre M, Thezenas S, Lamy PJ, Maran-Gonzalez A, Gutowski M, Colombo PE, Romieu G, Jacot W, Guiu S. Viala M, et al. Among authors: guiu s. Breast Cancer Res Treat. 2017 Oct;165(3):611-621. doi: 10.1007/s10549-017-4373-7. Epub 2017 Jul 6. Breast Cancer Res Treat. 2017. PMID: 28685212

8

Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers.

Guiu S, Mollevi C, Charon-Barra C, Boissière F, Crapez E, Chartron E, Lamy PJ, Gutowski M, Bourgier C, Romieu G, Simony-Lafontaine J, Jacot W. Guiu S, et al. Br J Cancer. 2018 Jul;119(1):76-79. doi: 10.1038/s41416-018-0142-6. Epub 2018 Jun 8. Br J Cancer. 2018. PMID: 29880907 Free PMC article.

9

Targeting homologous repair deficiency in breast and ovarian cancers: Biological pathways, preclinical and clinical data.

Chartron E, Theillet C, Guiu S, Jacot W. Chartron E, et al. Among authors: guiu s. Crit Rev Oncol Hematol. 2019 Jan;133:58-73. doi: 10.1016/j.critrevonc.2018.10.012. Epub 2018 Nov 5. Crit Rev Oncol Hematol. 2019. PMID: 30661659 Review.

10

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.

Darlix A, Hirtz C, Thezenas S, Maceski A, Gabelle A, Lopez-Crapez E, De Forges H, Firmin N, Guiu S, Jacot W, Lehmann S. Darlix A, et al. Among authors: guiu s. BMC Cancer. 2019 Jan 30;19(1):110. doi: 10.1186/s12885-019-5287-z. BMC Cancer. 2019. PMID: 30700265 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters